The encouraging results of the Malakit study and the challenge of continuing to work towards the elimination of malaria in the Guiana Shield region open up new perspectives.

The Malakit strategy, adopted by Suriname’s malaria program as an additional tool in their malaria control arsenal, is currently being deployed on the border between French Guiana and Suriname with the support of the Global Funds. Our team will continue to support this transfer and this scientific-institutional partnership with funding from French Guiana Health Regional Agency.

Exchanges with the Ministries of Health of France and Brazil allow us to support the reflection of these health authorities on the operational integration of the Malakit strategy for very specific populations in their territories. Regulatory obstacles and levers are currently being examined by the national technical teams.

On the scientific level, the data and biological samples are currently being analyzed, and will provide a wealth of additional information on the project and the health of our target population, the garimpeiros: sexually transmitted infections, zoonoses, heavy metal poisoning, etc.

Our team has also decided to take up the challenge of contributing to the elimination of Plasmodium vivax: a new operational research project is being developed to complement the Malakit strategy, with an intervention specifically targeting this parasite species.

 


Our ultimate objective:

To contribute to the international toolbox of strategies that can be mobilized for the control and elimination of malaria in isolated, mobile and clandestine populations, often suffering from residual malaria, which represents a real challenge for those involved in the fight against malaria in many countries around the world.

In this same perspective, and thanks to the funding granted by the TDR initiative (Tropical Diseases Research/WHO) to the Ministry of Health of Suriname, we wish to contribute to the organization of an international workshop dedicated to the sharing of experiences and evidence in the fight against malaria in these hard-to-reach, migrant and/or cross-border populations.

The coming months will be very rich, stay tuned to hear more!